Leslie T. Cooper, M.D., is the Elizabeth C. Lane and M. Nadine Zimmerman Professor of Internal Medicine and the chair of the Department of Cardiovascular Medicine at Mayo Clinic in Florida. Dr. Cooper's clinical interests and research focus on clinical and translational studies of rare and undiagnosed cardiomyopathies, myocarditis, inflammatory cardiac and vascular diseases such as giant cell myocarditis, cardiac sarcoidosis, eosinophilic myocarditis, and Takayasu's arteritis. He has published over 200 original peer-reviewed papers and over 100 book chapters, review articles and editorials on myocarditis. In addition, he has worked with clinicians and researchers around the world to further diagnosis, treatment, and care for myocarditis and cardiomyopathies. In addition to his clinical and research work, Dr. Cooper is a fellow of the American College of Cardiology, the American Heart Association, the European Society of Cardiology Heart Failure Association, the International Society for Heart and Lung Transplantation, and the Society for Vascular Medicine and Biology. He is also the founder and former president of the Myocarditis Foundation and continues to serve on their board of directors.

Dr Rajwani is a consultant cardiologist and clinical lead for echo at the Royal Perth Hospital, with interests in multimodality imaging (CMR, CTCA and echo).

Dr Jon Spiro is an interventional cardiologist at Royal Perth Hospital, with a special interest in coronary vasomotor disorders and microvascular function. Jon is the founder and clinical lead for the hospital's INOCA program and member of the CSANZ Vasomotor Dysfunction working group.

Associate Professor Sarah Zaman is an Interventional Cardiologist at Westmead Hospital and an Academic with the Westmead Applied Research Centre of the University of Sydney. A/Prof Zaman has been recognized as a national leader in academic cardiology as recipient of two prestigious National Heart Foundation Future Leader Fellowships and as a NSW Elite Post-doctoral Grant recipient. She has also been recognized internationally as a United States SCAI-ELM Fellow, a Lancet Commissioner on Atherosclerotic Heart Disease and on the writing committee for the Australian Acute Coronary Syndrome Guidelines. She leads the Australian-New Zealand SCAD registry and is National co-Lead for the international APT-SCAD randomised trial.

Graham Hillis is Head of the Department of Cardiology at Royal Perth Hospital, Clinical Professor of Medicine at the University of Western Australia, Adjunct Professor at Curtin University and Professorial Fellow at the George Institute for Global Health. From 2017 to 2020 he was also Director of Research for WA Health East Metropolitan Health Service. In addition to over 20 years of clinical cardiology experience, he has considerable expertise in the design, conduct and reporting of high quality clinical trials in cardiovascular medicine. He serves on the steering committees of several major national and international trials and on the end-point adjudication and data safety committees of several others. In particular, he is the international co-PI of the The Early valve replacement in severe ASYmptomatic aortic stenosis (EASY AS) trial, co-funded by the MRFF, British Heart Foundation and New Zealand Heart Foundation and CI on many other grants, including from the NHMRC, Heart Foundation and Canadian Institutes of Health Research (totalling >$17 million in the past 5 years). He has over 180 career publications, including many in leading general and speciality journals and has twice been awarded the National Heart Foundation Ross Hohnen Prize for Research Excellence (in 2014 and 2018).

John Beltrame is the Michell Professor in Medicine at the University of Adelaide and Director of Research for the Central Adelaide Local Health Network. He has strong clinical and research interests in coronary heart disease, especially in relation to coronary vasomotor disorders, which has evolved from his postgraduate studies in Rome, Kyoto and Boston. Along with Prof Noel Bairey Merz, he co-founded and co-chairs, COVADIS (Coronary Vasomotion Disorders International Study group), which promotes the diagnosis and treatment of patients afflicted with these disorders. His specific areas of expertise include the coronary slow flow phenomenon, vasospastic angina, MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries) and persistent angina after successful stenting (Post-PCI Angina). He is particularly interested in patient-related outcomes and developed the Coronary Angiogram Database of South Australia (CADOSA) to investigate the impact of these conditions upon patients.